BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20585099)

  • 21. Results of neoadjuvant short-course radiation therapy followed by transanal endoscopic microsurgery for t1-t2 n0 extraperitoneal rectal cancer.
    Arezzo A; Arolfo S; Allaix ME; Munoz F; Cassoni P; Monagheddu C; Ricardi U; Ciccone G; Morino M
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):299-306. PubMed ID: 25772184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study.
    Bregendahl S; Emmertsen KJ; Lous J; Laurberg S
    Colorectal Dis; 2013 Sep; 15(9):1130-9. PubMed ID: 23581977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term quality of life and sexual and urinary function after abdominoperineal resection for distal rectal cancer.
    Kasparek MS; Hassan I; Cima RR; Larson DR; Gullerud RE; Wolff BG
    Dis Colon Rectum; 2012 Feb; 55(2):147-54. PubMed ID: 22228157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.
    Brændengen M; Tveit KM; Bruheim K; Cvancarova M; Berglund Å; Glimelius B
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1017-24. PubMed ID: 20932687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
    Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
    J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Quality of Life and Functional Outcome of Patients With Rectal Cancer Following a Watch-and-Wait Approach.
    Custers PA; van der Sande ME; Grotenhuis BA; Peters FP; van Kuijk SMJ; Beets GL; Breukink SO;
    JAMA Surg; 2023 May; 158(5):e230146. PubMed ID: 36988922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T; Gu J; Li M; Du C
    Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party.
    Lancet; 1996 Dec; 348(9042):1610-4. PubMed ID: 8961990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer.
    Urso E; Serpentini S; Pucciarelli S; De Salvo GL; Friso ML; Fabris G; Lonardi S; Ferraro B; Bruttocao A; Aschele C; Nitti D
    Eur J Surg Oncol; 2006 Dec; 32(10):1201-8. PubMed ID: 16872799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
    Guckenberger M; Saur G; Wehner D; Thalheimer A; Kim M; Germer CT; Flentje M
    Radiother Oncol; 2013 Aug; 108(2):326-30. PubMed ID: 24021342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Neoadjuvant Therapy and Rectal Surgery on Health-related Quality of Life in Patients With Rectal Cancer During the First 2 Years After Diagnosis.
    Couwenberg AM; Burbach JPM; van Grevenstein WMU; Smits AB; Consten ECJ; Schiphorst AHW; Wijffels NAT; Heikens JT; Intven MPW; Verkooijen HM
    Clin Colorectal Cancer; 2018 Sep; 17(3):e499-e512. PubMed ID: 29678514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effect of preoperative radiation therapy on anorectal function.
    Pollack J; Holm T; Cedermark B; Holmström B; Mellgren A
    Dis Colon Rectum; 2006 Mar; 49(3):345-52. PubMed ID: 16532369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score.
    Battersby NJ; Bouliotis G; Emmertsen KJ; Juul T; Glynne-Jones R; Branagan G; Christensen P; Laurberg S; Moran BJ;
    Gut; 2018 Apr; 67(4):688-696. PubMed ID: 28115491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of Life after Endoluminal Loco-Regional Resection (ELRR) by Transanal Endoscopic Microsurgery (TEM).
    D'Ambrosio G; Balla A; Mattei F; Quaresima S; De Laurentis F; Paganini AM
    Ann Ital Chir; 2015; 86(1):56-60. PubMed ID: 25816918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Outcomes and Health-Related Quality of Life After Curative Treatment for Rectal Cancer: A Population-Level Study in England.
    Downing A; Glaser AW; Finan PJ; Wright P; Thomas JD; Gilbert A; Corner J; Richards M; Morris EJA; Sebag-Montefiore D
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1132-1142. PubMed ID: 30553942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in mortality, quality of life and function after restorative procedures for rectal cancer.
    Zutshi M; Hull T; Shedda S; Lavery I; Hammel J
    Colorectal Dis; 2013 Jan; 15(1):66-73. PubMed ID: 22564198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for sexual dysfunction after rectal cancer treatment.
    Lange MM; Marijnen CA; Maas CP; Putter H; Rutten HJ; Stiggelbout AM; Meershoek-Klein Kranenbarg E; van de Velde CJ;
    Eur J Cancer; 2009 Jun; 45(9):1578-88. PubMed ID: 19147343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy.
    Wiltink LM; Nout RA; van der Voort van Zyp JR; Ceha HM; Fiocco M; Meershoek-Klein Kranenbarg E; Marinelli AW; van de Velde CJ; Marijnen CA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e93-9. PubMed ID: 26968237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
    Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
    Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.